|Bid||27.76 x 800|
|Ask||28.38 x 800|
|Day's Range||27.76 - 28.28|
|52 Week Range||16.08 - 34.80|
|Beta (5Y Monthly)||1.71|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 01, 2021 - Nov. 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov. 10, 2010|
|1y Target Est||36.08|
A look at the shareholders of Bausch Health Companies Inc. ( NYSE:BHC ) can tell us which group is most powerful...
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its third-quarter 2021 financial results on Tuesday, Nov. 2, 2021. Bausch Health will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
ALPHARETTA, Ga., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that multiple presentations were given at the Retina Society 54th Annual Scientific Meeting which took place September 29 – October 2, 2021 in Chicago, IL. “These presentations demonstrate the targeted and compartmentalized nature